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ABSTRACT
Laparoscopic myomectomy has recently gained wide
acceptance. However, this procedure remains technically
highly demanding and concerns have been raised
regarding the prolonged time of anesthesia, increased
blood loss, and possibly a higher risk of postoperative
adhesion formation. Laparoscopic-assisted myomectomy
(LAM) is advocated as a technique that may lessen these
concerns regarding laparoscopic myomectomy while
retaining the benefits of laparoscopic surgery, namely,
short hospital stay, lower costs, and rapid recovery. By
decreasing the technical demands, and thereby the oper-
ative time, LAM may be more widely offered to patients.
In carefully selected cases, LAM is a safe and efficient alter-
native to both laparoscopic myomectomy and myomectomy
by laparotomy. These cases include patients with numerous
large or deep intramural myomas. LAM allows easier repair
of the uterus and rapid morcellation of the myomas. In
women who desire a future pregnancy, LAM may be a bet-
ter approach because it allows meticulous suturing of the
uterine defect in layers and thereby eliminates excessive
electrocoagulation.
Key Words: Laparoscopy, Myomectomy, Uterine leiomy-
omata, Morcellation, Suturing.
INTRODUCTION
Uterine leiomyomata, the most common solid pelvic
tumors, occur in approximately 20% of women aged 35
years or more.1 Because of the significant operative risk
associated with abdominal myomectomy, the operation
has been reserved for women who want to preserve or
enhance their fertility potential.2,3 However, with the gen-
eral trend towards conserving the uterus and because
many women currently choose delayed childbearing,
patient demand for this procedure has increased.4-6
Furthermore, with the improvement in laparoscopic tech-
niques and their associated low morbidity, resection of
myomas is now a valid alternative for women suffering
from any serious symptoms related to the presence of
myomas in the uterus. Such symptoms commonly include
dysfunctional uterine bleeding, pain, and infertility.6-9
The only surgical treatment available for intramural and
subserous myomas in the past was laparotomy.2 This pro-
cedure was associated with a relatively high level of mor-
bidity.2 Laparoscopic myomectomy has since been shown
to be an effective means of reducing postoperative mor-
bidity, and it expedites recuperation. However, it quickly
became apparent that the laparoscopic operation was
associated with the prolonged time of anesthesia, in-
creased blood loss, and possibly a higher risk of postop-
erative adhesion formation.10,11
Laparoscopic myomectomy was described 2 decades ago
and has since been repeatedly shown to provide the rec-
ognized benefits of the laparoscopic approach.12-15
However, with increasing experience, it has become
apparent that the technique demands a high degree of
training and skill from the laparoscopic operator.10,16 It has
been suggested that at present these factors limit the appli-
cation of laparoscopic myomectomy.16 
Despite significant improvements in endoscopic instru-
mentation, laparoscopic myomectomy remains a techni-
cally demanding and time-consuming procedure. In the
easiest cases, pedunculated myomas may be simply tran-
sected, and some enucleated myomas will “pop out”
through an incision in the uterine wall. However, in many
instances, the incision of intramural myomas is technical-
ly challenging. Mastery of laparoscopic suturing is also a
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crucial requirement for laparoscopic myomectomy.17
The operation is time-consuming,10 usually because of the
difficulty in morcellating and removing the myoma from
the abdominal cavity through the laparoscopic trocar ports
or a posterior colpotomy. The belief that the strength of
the uterine scar may be compromised is based on 2 major
considerations and is supported by 5 reports of uterine
dehiscence during pregnancy.18-22 First, the difficulty in
adequately reapproximating the incision, as with meticu-
lous multilayer suturing, may lead to the accumulation of
an intramural hematoma. Second, use of the CO2 laser and
electrodesiccation, which could lead to thermal injury to
surrounding tissue, may result in poor vascularization and
tissue necrosis.8,14
At second-look laparoscopy, we have observed indenta-
tions at the sites from which leiomyomas were removed
that were directly proportioned to the size of the myomas
removed and may therefore represent structural defects.
Uteroperitoneal fistulas also have been noted after laparo-
scopic myomectomy.23 Adhesion formation may be more
numerous and dense around laparoscopically sutured uter-
ine incisions.24 This is a significant potential problem when
the myomectomy is performed to enhance or preserve fer-
tility. However, data are still limited concerning postsurgi-
cal adhesion formation and pregnancy outcome6 although
some preliminary data are encouraging.7,9,15,25 Another
concern recently raised is the possibility that, after incom-
plete resection of the uterine myomas, the recurrence of
myomas may be higher with the laparoscopic approach.26
Nezhat et al24 developed laparoscopic-assisted myomecto-
my (LAM) and reported on it in 1994. It has been advocat-
ed as a technique that may lessen these concerns regarding
laparoscopic myomectomy while retaining the benefits of
laparoscopic surgery, namely, short hospital stay, lower
costs, and rapid recovery.24 Herein, the LAM technique and
possible associated advantages are described.
METHODS
Whether to proceed with LAM is usually decided in the
operating room after first completing the diagnostic
laparoscopy and treating any associated pathology. The
criteria for LAM are myomas larger than 10 to 12 cm or
numerous and deep myomas requiring extensive morcel-
lation and necessitating uterine repair with sutures.
The leiomyoma, or in patients with multiple myomas, the
most prominent one, is injected at its base with 3 to 7 mL
of diluted vasopressin to minimize blood loss. An incision
is made over the uterine serosa until the capsule of the
leiomyoma is reached.27 A corkscrew manipulator is
inserted into the leiomyoma and used to elevate the uterus
toward the midline suprapubic puncture. With the trocar
and manipulator attached to the myoma, the midline 5-
mm puncture is enlarged to a 4- to 5-cm transverse inci-
sion. After incision of the fascia transversely at 4 to 5 cm,
the rectus muscles are separated at the midline.
We do not routinely use preoperative gonadotrophin-
releasing hormone (GnRH) analogues. For anemic
patients, preoperative treatment with GnRH analogues
may enable restoration of a normal hematocrit, decrease
the size of the myomas,28 and reduce the need for trans-
fusion.29,30 However, the benefits of preoperative treat-
ment with GnRH analogues for laparoscopic myomectomy
have recently been challenged in a prospective random-
ized study.11 
The peritoneum is entered transversely, and the leiomy-
oma is located and brought to the incision using the
corkscrew manipulator; a uterine manipulator is used to
raise the uterus. The corkscrew manipulator is replaced
with 2 Lahey tenacula. The leiomyoma is shelled sequen-
tially and morcellated, gradually exposing new areas. After
complete removal of the leiomyoma, the uterine wall
defect is seen through the incision. If uterine size allows,
the uterus is brought to the skin through the minilaparo-
tomy incision to complete the repair. When multiple
leiomyomas are found, as many as possible are removed
through a single uterine incision. When the leiomyomas
are in distant locations and identification is impossible, the
minilaparotomy incision is closed temporarily with 1 layer
of running suture or several Allis clamps. The laparoscope
is reintroduced, and the leiomyomas are identified and
brought to the incision. If posterior leiomyomas are diffi-
cult to reach through a minilaparotomy incision, they are
removed completely laparoscopically. The uterus is then
exteriorized through the minilaparotomy incision.
The uterus is reconstructed in layers using 4-0 to 2-0 and
0-polydioxanone suture without suturing the serosa, and
the uterus is palpated to ensure that no small intramural
leiomyomas are present. The uterus is returned to the peri-
toneal cavity, and the fascia and skin are closed in layers.
The fascia is closed with 1-0 polyglactin suture, and the
skin is closed in a subcuticular manner. The laparoscope
is used to evaluate the uterus and ensure final hemostasis.
The pelvis is evaluated to detect and treat endometriosisand adhesions that may have been obscured previously by
myomas. Copious irrigation is performed, and blood clots
are removed.
RESULTS
Laparoscopic-assisted myomectomy outcomes were com-
pared with the results in patients who had either myomec-
tomy by laparotomy or laparoscopic myomectomy.24 The
myoma weight was significantly greater in the LAM group
than in the patients undergoing laparoscopic myomecto-
my. It was found that LAM could safely replace myomec-
tomy by laparotomy, because patient selection criteria
were comparable, and the myoma weights of these 2
groups were similar.
The mean estimated blood loss of the LAM and laparoto-
my groups was not different. In contrast, blood loss
among the patients undergoing laparoscopic myomecto-
my was significantly lower and may be attributed to the
smaller myomas removed.24
Previous studies have underscored the need to decrease
the operating time of laparoscopic myomectomy.10
Although subserosal myomas less than 5 cm can be man-
aged easily laparoscopically, larger and intramural lesions
require prolonged morcellation and laparoscopic suturing
of the uterine defect. The largest reported myomas
removed by laparoscopy have been 15 to 16 cm.13,14 Some
surgeons have suggested that the size of the myoma to be
removed laparoscopically should be limited to 10 cm31 or
even 6 to 7 cm.32,33 Both laparoscopic morcellation and
myometrial suturing are difficult and time-consuming.
Consequently, it has also been suggested that no more
than 4 myomas, 3 cm or more in size, should be attempt-
ed to be removed laparoscopically.31,32
LAM, with conventional morcellation and suturing through
the minilaparotomy incisions, allows fast removal of multi-
ple and large myomas and reduces the duration of the oper-
ation and the need for extensive laparoscopic experience.
Similar mean operating times for laparoscopic myomecto-
my and LAM techniques were observed despite larger
myomas and their intramural positions, adjunctive laparo-
scopic procedures, and the smaller incisions in the LAM
groups.24
Hospitalization was significantly longer for the patients
who underwent myomectomy by laparotomy when com-
pared with that for the groups having LAM or laparoscop-
ic myomectomy.24 Currently, the hospitalization time is
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similar for patients undergoing LAM and patients having
laparoscopic myomectomy. For both procedures, day sur-
gery is used, and the patient is usually discharged on the
first postoperative day. The postoperative recovery time is
comparable for patients undergoing LAM versus laparo-
scopic myomectomy, despite the differences in the size of
the different incisions. 
DISCUSSION
The use of LAM offers several obvious and potential long-
and short-term benefits (Table 1). The major advantages
of LAM are ease of repair of the uterus and rapid morcel-
lation of the fibroids. In addition, LAM allows more metic-
ulous suturing of the uterus, thus maintaining better uter-
ine wall integrity. 
The most feared postoperative complication, uterine rup-
ture during pregnancy, has been reported to date in 5
cases after laparoscopic myomectomy.18-22 Because the
number of procedures performed over the last few years
remains unknown, it is difficult to determine whether
these 5 cases represent an incidence higher or lower than
expected after any myomectomy. Uterine rupture after
myomectomy is rare, but has been reported to account for
approximately 2% of all pregnancy-related uterine rup-
tures.34 All large series reported to date did not confirm





Technically easier to perform 
Thorough repair of the uterus
Easier morcellation of myomas
Fast removal of bulky tissue
Reduced operation time 
Rapid recovery typical of laparoscopy
Long-term benefits
More complete removal of myomas
Higher fertility rates
Lower recurrence of myomas 
Maintaining uterine wall integrity
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ed with an increased risk for uterine dehiscence during
pregnancy.7-9,15 However, it must be remembered that
inadequate approximation of the uterine wall and poor
healing may predispose patients to uterine rupture.18 
Second-look laparoscopies performed on postmyomecto-
my patients with pedunculated and superficial subserosal
myomas show complete uterine healing. In contrast, intra-
mural and deep subserosal myomas are associated with
evidence of granulation tissue and indentation of the
uterus proportional to the size of the leiomyoma removed,
unless sutures are used to approximate the edges. The use
of sutures is associated with a higher rate of adhesions.24
In a recent study of second-look after laparoscopic
myomectomy, 72 myomectomy sites were checked.14 The
overall rate of postoperative adhesion was 35.6% per
patient. The rate of adhesions per myomectomy site was
16.7%. The factors that influenced the occurrence of an
adhesion on the myomectomy site were posterior location
of the myoma and the existence of sutures.14 Meticulous
suturing techniques facilitated by LAM may therefore
reduce the rate of postoperative adhesions.24
In patients with intramural fibroids and significant uterine
wall defects, an unacceptably high rate of endometrial-
serosal fistula occurs. Currently, the meticulous suturing
made possible during laparotomy is very challenging to
perform at laparoscopy. LAM therefore may provide a safer
approach allowing more complete multilayer correction of
the postmyomectomy uterine defects. 
A similar approach, combined laparoscopic and vaginal
myomectomy, has also been suggested for treating exten-
sive and deeply infiltrating fundal and posterior wall
leiomyomata.35 The posterior colpotomy permits delivery
of the myomas and allows uterine reconstruction by con-
ventional suturing performed transvaginally. This approach
also permits layered traditional uterine reconstruction of
deep myometrial defects. 
A long-established dogma dictates that, if the endometrial
cavity is entered or a submucous or large intrauterine
myoma is removed during abdominal myomectomy, the
patient should undergo cesarean delivery for subsequent
pregnancies.24 Similar guidelines should be followed for
laparoscopic myomectomies and LAM. Currently, women
with large intramural fibroids, who wish to have children,
should be strongly cautioned regarding the relative pauci-
ty of data regarding the precise risk during pregnancy after
laparoscopic myomectomy.
CONCLUSION
LAM, in carefully selected cases, is a safe and efficient
alternative to both laparoscopic myomectomy and
myomectomy by laparotomy. These cases include patients
with numerous, large or deep intramural myomas. LAM
allows easier repair of the uterus and rapid morcellation of
the myomas. LAM may also be a more appropriate ap-
proach for women who desire a future pregnancy because
uterine healing and adhesion formation remain a signifi-
cant concern. In such women, LAM may offer better man-
agement, because it allows careful suturing of the uterine
defect in layers and avoids excessive electrocoagulation.
By decreasing the technical demands, and thereby the
operative time, LAM may be more widely offered to
patients. Thus, providing them with the well-recognized
advantages of minimal access surgery, including a shorter
hospital stay, and better patient convenience and recovery.
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